Open Forum Infect Dis . Antiviral Prescribing Among Patients at an Ambulatory Cancer Center With Laboratory-Confirmed Influenza

[tetano]

Open Forum Infect Dis


. 2023 May 10;10(5):ofad254.
doi: 10.1093/ofid/ofad254. eCollection 2023 May. Antiviral Prescribing Among Patients at an Ambulatory Cancer Center With Laboratory-Confirmed Influenza

Woody Sorey ¹ , Elizabeth M Krantz ² , Jessica Morris ² , John Klaassen ² , Ania Sweet ^{2 3} , Frank Tverdek ^{2 3} , Zahra K Escobar ^{2 3} , Denise J McCulloch ^{1 2 4} , Steven A Pergam ^{1 2 4} , Catherine Liu ^{1 2 4}



Affiliations

• PMID: 37250175
• PMCID: PMC10220506
• DOI: 10.1093/ofid/ofad254

Abstract

Among 133 cancer outpatients diagnosed with influenza between 2016 and 2018, 110 (83%) were prescribed oseltamivir. Among 109 with a known symptom onset date, 53% presented for care and 31% were prescribed oseltamivir within 48 hours. Patient/provider education and rapid diagnostics are needed to improve early oseltamivir use among cancer patients with influenza.

Keywords: ambulatory setting; antibiotic prescribing; cancer patients; influenza; oseltamivir prescribing; rapid diagnostics.